Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Dialysis Clinical Outcomes Revisited (DCOR) Trial

ClinicalTrials.gov ID: NCT00324571

Public ClinicalTrials.gov record NCT00324571. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 4:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open Label, Parallel Design Study of Renagel® Phosphate Binder Versus Calcium-Based Phosphate Binders in Hemodialysis Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, open-label, parallel-design study to be conducted at 75 centers within the United States. The study will be described to hemodialysis patients. Informed consent will be obtained and the inclusion/exclusion criteria reviewed. Eligible patients will be randomized to receive either Renagel or a calcium-based binder. Starting from the randomization date, mortality data including survival, death date and cause of death (vital status information) and morbidity data including hospitalization date will be recorded for all patients. These data will be collected until the end of the study (December 31, 2004, ± 2 weeks). Patients completing or terminating from the study will return to the phosphate binder prescribed by their usual healthcare provider.

Study identification

NCT ID
NCT00324571
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Genzyme, a Sanofi Company
Industry
Enrollment
2,000 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2001
Primary completion
Not listed
Completion
Jan 31, 2006
Last update posted
Mar 17, 2015

2001 – 2006

United States locations

U.S. sites
72
U.S. states
26
U.S. cities
66
Facility City State ZIP Site status
Gambro Healthcare-Gadsden Gadsden Alabama
nTouch Research Huntsville Alabama
Kidney Health Institute, LLC Tucson Arizona
Gambro Healthcare El Cerrito California
Palomar Medical Group Escondido California
Gambro Healthcare-Los Angeles Los Angeles California
Balboa Nephrology Medical Group San Diego California
Nephrology Educational Services and Research Tarzana California
Lowry Dialysis Center Denver Colorado
Nephrology Associates, P.C. Bridgeport Connecticut
Gambro Healthcare-Hartford Hartford Connecticut
Nephrology Associates New Britain Connecticut
InterAmerican Dialysis Coral Gables Florida
DaVita Crystal River Dialysis Crystal River Florida
Gambro Healthcare-Miami Miami Florida
Miami Kidney Group Miami Florida
Pensacola Nephrology, P.A. Pensacola Florida
Gambro Healthcare-Plantation Plantation Florida
America Dialysis St. Petersburg Florida
Genesis Clinical Research Corp Tampa Florida
Gambro Healthcare-Americus Americus Georgia
nTouch Research Atlanta Georgia
Gambro Healthcare-Douglas Douglas Georgia
Gambro Healthcare-Douglasville Douglasville Georgia
Dublin Nephrology Dublin Georgia
Georgia Kidney Associates, Inc. Marietta Georgia
Gambro Healthcare-Rome Rome Georgia
Gambro Healthcare-Savannah Savannah Georgia
MacNeal Renal Lifeline Services Berwyn Illinois
Southwest Nephrology Evergreen Park Illinois
Horizon Healthcare Associates Olympia Fields Illinois
Renal Care Associates, S.C. Peoria Illinois
Gambro Healthcare-Springfield Central Springfield Illinois
Lincolnland Dialysis Springfield Illinois
Nephrology Specialists, PC. Valparaiso Indiana
Wichita Dialysis Center East Wichita Kansas
Wichita Nephrology Wichita Kansas
Northwest Louisiana Nephrology, LLC. Shreveport Louisiana
BMA of Washington Bethesda Maryland
Gambro Healthcare-Frederick Frederick Maryland
Associates in Nephrology, P.C. Brockton Massachusetts
Western New England Renal and Transplant Associates, Inc. Springfield Massachusetts
DaVita Clinical Research Minneapolis Minnesota
Nephrology Associates, P.C. Columbus Mississippi 39705
University of Missouri-Kansas City Kansas City Missouri
DaVita Crystal City Dialysis St Louis Missouri
Nephrology and Endocrine Associates Las Vegas Nevada
Bronx Westchester Medical Group The Bronx New York
Mountain Kidney Associates, P.A. Asheville North Carolina
nTouch Research Raleigh North Carolina
Wake Nephrology/Wake Dialysis Clinic Raleigh North Carolina
Gambro Healthcare-Wilson Wilson North Carolina
Kidney and Hypertension Center Cincinnati Ohio 45220
Ohio State University College of Pharmacy Columbus Ohio
FMC of Bethlehem Allentown Pennsylvania
Fresenius Medical Care Greensburg Pennsylvania
Hypertension and Kidney Specialists Lancaster Pennsylvania
DaVita Lewistown Dialysis Center Lewistown Pennsylvania
Albert Einstein Medical Center Philadelphia Pennsylvania 19141
P.C. & Associates Philadelphia Pennsylvania
Nesbitt College of Pharmacy and Nursing Department of Pharmacy Practice Wilkes-Barre Pennsylvania
Gambro Healthcare-Aiken Aiken South Carolina
Midsouth Nephrology Consultants Memphis Tennessee
Dallas Nephrology Associates Dallas Texas
Nephrology, Dialysis and Transplant Association Houston Texas
West Houston Dialysis Houston Texas
San Antonio Kidney Disease Center San Antonio Texas
Gambro Healthcare - Charlottesville Charlottesville Virginia 22902
Clinical Research and Consulting Center, LLC Fairfax Virginia
Clinical Research of Tidewater Norfolk Virginia 23507
Virginia Commonwealth University, Division of Nephrology Richmond Virginia 23298
Vancouver Clinic Inc., P.S. Vancouver Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00324571, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 17, 2015 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00324571 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →